Charles Schwab’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Sell
1,111,891
-24,811
-2% -$222K ﹤0.01% 2047
2025
Q4
$9.62M Buy
1,136,702
+25,371
+2% +$181K ﹤0.01% 2163
2025
Q3
$5.8M Buy
1,111,331
+5,071
+0.5% +$19.3K ﹤0.01% 2370
2025
Q2
$3.83M Buy
1,106,260
+41,402
+4% +$123K ﹤0.01% 2445
2025
Q1
$2.79M Buy
1,064,858
+54,051
+5% +$212K ﹤0.01% 2511
2024
Q4
$4.16M Sell
1,010,807
-24,982
-2% -$136K ﹤0.01% 2418
2024
Q3
$7.33M Buy
1,035,789
+214,398
+26% +$1.6M ﹤0.01% 2182
2024
Q2
$5.36M Sell
821,391
-90,766
-10% -$620K ﹤0.01% 2334
2024
Q1
$7.57M Buy
912,157
+34,344
+4% +$335K ﹤0.01% 2124
2023
Q4
$9.66M Buy
877,813
+163,008
+23% +$1.38M ﹤0.01% 2002
2023
Q3
$6.01M Buy
714,805
+42,411
+6% +$456K ﹤0.01% 2173
2023
Q2
$8.45M Buy
672,394
+18,512
+3% +$230K ﹤0.01% 1984
2023
Q1
$10.8M Sell
653,882
-561
-0.1% -$10.1K ﹤0.01% 1839
2022
Q4
$9.78M Buy
654,443
+35,476
+6% +$679K ﹤0.01% 1871
2022
Q3
$13.8M Buy
618,967
+73,483
+13% +$1.61M 0.01% 1640
2022
Q2
$9.14M Buy
545,484
+894
+0.2% +$19.2K ﹤0.01% 1881
2022
Q1
$16.3M Buy
544,590
+16,572
+3% +$402K ﹤0.01% 1688
2021
Q4
$16.2M Buy
528,018
+99,696
+23% +$3.15M ﹤0.01% 1737
2021
Q3
$13.5M Buy
428,322
+205,352
+92% +$6.91M ﹤0.01% 1837
2021
Q2
$8.16M Buy
222,970
+28,779
+15% +$948K ﹤0.01% 2106
2021
Q1
$6.71M Buy
194,191
+34,628
+22% +$1.5M ﹤0.01% 2155
2020
Q4
$6.63M Buy
159,563
+4,520
+3% +$204K ﹤0.01% 2083
2020
Q3
$6.6M Buy
+155,043
New +$5.91M ﹤0.01% 1936

Other funds holding RLAY